All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

1,268

Reset

1,268 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • Relmada Therapeutics, Inc. · Bladder (Urothelial, Transitional Cell) Cancer, Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive), Urothelial Carcinoma Bladder

  • SuvemcitugPhase 31 trial

    Jiangsu Simcere Pharmaceutical Co., Ltd. · Refractory Metastatic Colorectal Cancer

  • TBI-1301Phase 31 trial

    Takara Bio Inc. · Synovial Sarcomas

  • TilesizumabBGB-108Phase 31 trial

    Qilu Pharmaceutical Co., Ltd. · Lung Cancer

  • UtomilumabPhase 31 trial

    Pfizer · Advanced Malignancies, NSCLC, Ovarian Cancer

  • varegacestatAL102Phase 31 trial

    Immunome, Inc. · Desmoid, Desmoid Tumor

  • VC004Phase 31 trial

    Jiangsu vcare pharmaceutical technology co., LTD · Locally Advanced Solid Tumor

  • YK-209APhase 31 trial

    Suzhou Puhe Pharmaceutical Technology Co., LTD · Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

  • ZovegalisibPhase 31 trial

    Relay Therapeutics, Inc. · PIK3CA Mutation, HER2- Negative Breast Cancer, Hormone Receptor Positive Tumor

  • MK-4830Phase 210 trials

    Merck & Co. · Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, Esophageal Squamous Cell Carcinoma

  • SI-B003Phase 210 trials

    Sichuan Baili Pharmaceutical Co., Ltd. · Non-small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma of Head and Neck

  • SHR-9839Phase 28 trials

    Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Advanced Solid Tumors, Advanced Esophageal Squamous Cell Carcinoma, Non-small Cell Lung Cancer (NSCLC)

  • BL-M08D1Phase 26 trials

    Sichuan Baili Pharmaceutical Co., Ltd. · Solid Tumors, Gastrointestinal Tumors, Diffuse Large B-Cell Lymphoma

  • RO7247669Tobemstomig, RG6139Phase 26 trials

    Roche (Genentech) · Solid Tumors, Metastatic Melanoma, Non-small Cell Lung Cancer

  • SKB571Phase 26 trials

    Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Lung Cancer (Non-Small Cell), Non-Small Cell Lung Cancer, Gastrointestinal Tumors

  • VibostolimabMK-7684Phase 26 trials

    Merck & Co. · Melanoma, Carcinoma, Non-Small-Cell Lung, Metastatic Urothelial Carcinoma

  • Dual-target CAR-NK cellsEB-DT-CAR-NK, Essen Biotech Dual-Target CAR-NKPhase 25 trials

    Beijing Biotech · HER2-positive Breast Cancer, Non-Small Cell Lung Cancer, Breast Cancer (Locally Advanced or Metastatic)

  • EvorpaceptALX148Phase 25 trials

    ALX Oncology Inc. · Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Breast Cancer, Metastatic

  • GFH276Phase 25 trials

    Genfleet Therapeutics (Shanghai) Inc. · RAS Mutation, Pancreatic Cancer, Non-small Cell Lung Cancer (NSCLC)

  • PalacaparibAZD9574Phase 25 trials

    AstraZeneca · Metastatic Prostate Cancer, Ovarian Cancer, Endometrial Cancer

  • SHR-1826Phase 25 trials

    Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Non-small Cell Lung Cancer (NSCLC), Non-Small Cell Lung Cancer, Resectable Non-small Cell Lung Cancer

  • zamtocabtagene autoleucelMB-CART2019.1Phase 25 trials

    Miltenyi Biomedicine GmbH · CAR T Cell Therapy, Mantle Cell Lymphoma (MCL), Multiple Sclerosis

  • Zelenectide pevedotinBT8009Phase 25 trials

    BicycleTx Limited · Breast Cancer, Non-Small Cell Lung Cancer, Advanced Solid Tumors

  • AB928Etrumadenant, ETRUMAPhase 24 trials

    Arcus Biosciences, Inc. · Lung Cancer, Advanced or Metastatic Non-Small-Cell Lung Cancer, Resectable Non-Small-Cell Lung Cancer

  • ABSK043Phase 24 trials

    Abbisko Therapeutics Co, Ltd · Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer With EGFR-mutated and PD-L1 Positive, HER2-Gastric/Gastroesophageal Junction Cancer

  • APG-115Phase 24 trials

    Ascentage Pharma Group Inc. · T-Prolymphocytic Leukemia, Non-Hodgkins Lymphoma, Liposarcoma

  • BenmelstobartPhase 24 trials

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · Alveolar Soft Part Sarcoma, Non-Small Cell Lung Cancer, Gastroesophageal Adenocarcinoma

  • BotensilimabAGEN1181, 8541APhase 24 trials

    Agenus Inc. · Metastatic Colorectal Cancer, Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC), Untreated

  • DabogratinibTYRA-300Phase 24 trials

    Tyra Biosciences, Inc · FGFR3 Gene Mutation, FGFR3 Gene Alteration, Achondroplasia

  • EnvafolimabPhase 24 trials

    3D Medicines (Sichuan) Co., Ltd. · Biliary Tract Neoplasms, Solid Tumor, Solid Tumors

  • FPI-2265AZD2265, 225Ac-PSMA-I&TPhase 24 trials

    Fusion Pharmaceuticals Inc. · Metastatic Castration-resistant Prostate Cancer, Metastatic Prostate Cancer, Metastatic Castration Resistant Prostate Cancer

  • GecacitinibPhase 24 trials

    Suzhou Zelgen Biopharmaceuticals Co.,Ltd · Lymphoma, Non-small Cell Lung Cancer, Advanced Solid Tumor

  • IL-2MDNA11, Interleukin-2 -albuminPhase 24 trials

    Grit Biotechnology · Advanced Solid Tumor, Unresectable Solid Tumor, Clear Cell Renal Cell Carcinoma

  • INO-9012Phase 24 trials

    Geneos Therapeutics · HCC, Glioblastoma, Urothelial Carcinoma

  • luxdegalutamideJSB462, ARV-766Phase 24 trials

    Novartis · Prostatic Cancer, Castration-Resistant, Progressive Metastatic Castrate Resistant Prostate Cancer, Prostate Cancer Metastatic

  • MHB039APhase 24 trials

    Minghui Pharmaceutical (Hangzhou) Ltd · Advanced Malignant Solid Tumor, Advanced Breast Cancer, Advanced Lung Cancer

  • MK-2010LM-299Phase 24 trials

    Merck & Co. · Advanced Solid Tumors, Malignant Neoplasm, Malignant Tumors

  • MK-3120SKB410Phase 24 trials

    Merck & Co. · Bladder Cancer, Advanced Solid Tumors, Malignant Neoplasm

  • RO7198457Autogene CevumeranPhase 24 trials

    Roche (Genentech) · Colorectal Cancer Stage II, Colorectal Cancer Stage III, Adenocarcinoma, Pancreatic Ductal

  • T3011Phase 24 trials

    Shanghai Pharmaceuticals Holding Co., Ltd · Advanced Solid Tumors, Nonmuscle-invasive Bladder Cancer, Solid Tumor

  • TUB-040Phase 24 trials

    Gilead Sciences · Ovarian Cancer, Non-small Cell Lung Cancer, Uterine Endometrial Cancer

  • UbamatamabREGN4018Phase 24 trials

    Regeneron · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer

  • VS-7375Phase 24 trials

    Verastem, Inc. · G12D Mutated KRAS, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma (PDAC)

  • ADCAntibody-drug conjugate, ADCE-D01Phase 23 trials

    MBrace Therapeutics · Prostate Cancer Castration-resistant Prostate Cancer, Breast Cancer, Colo-rectal Cancer

  • ADG126Phase 23 trials

    Adagene Inc · Advanced/Metastatic Solid Tumors, Solid Tumor, Advanced Liver Cancers

  • AK130Phase 23 trials

    Akeso · Biliary Tract Cancer, Hepatocellular Carcinoma, Pancreatic Cancer

  • AK146D1Phase 23 trials

    Akeso · Advanced Non Small Cell Lung Cancer (NSCLC), Advanced Breast Cancer, Urothelial Carcinoma (UC)

  • AlisertibPB-8237, MLN8237Phase 23 trials

    Puma Biotechnology, Inc. · Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer, Recurrent Breast Cancer

  • AnvumetostatAMG 193Phase 23 trials

    Amgen · Advanced MTAP-null Solid Tumors, MTAP-deleted NSCLC, MTAP-null Non-Small-Cell Lung Cancer

  • AZD4205Phase 23 trials

    Dizal Pharmaceuticals · Non-small Cell Lung Cancer, Peripheral T-cell Lymphoma, Peripheral T Cell Lymphoma

NewerPage 9 of 26Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.